多替阿巴拉米片中国哪里有售?
On January 22, 2018, GlaxoSmithKline (GSK) announced that its single-tablet compound preparation (dolutegravir tablets, Inbec) with the new generation integrase inhibitor dolutegravir (DTG) as the core for the treatment of HIV was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.
After Suimeikai is launched in China, patients can buy it in some large domestic hospitals with prescriptions issued by doctors, without having to go abroad, which is more convenient. However, as an original drug, the price of Suimeikai is relatively high, which puts many patients under great long-term financial pressure.
Medical Travel understands that Suimeikai is currently on the market in India. It is produced by Emcure. The effect is the same as the original domestic drug. Each box contains 30 tablets. The price is about $1,000, which is much lower than the domestic price. It is a good choice for patients. If it is inconvenient for patients to go abroad, they can also use direct mail through Medical Companion Travel to send medicines directly from Indian pharmacies to patients, and patients do not have to worry about buying counterfeit medicines.
Contraindicated in patients with known hypersensitivity to dolutegravir, abacavir, and lamivudine or any excipients. Concomitant use with dofetilide and pisicanide is prohibited. Transmitting HIV Although effective viral suppression with antiretroviral treatment has been shown to significantly reduce the risk of sexual transmission, residual risks cannot be ruled out. Precautions should be taken to prevent transmission in accordance with national guidance. There are limited data on the use of dolutegravir, abacavir, and lamivudine in patients 65 years and older. There is no evidence that older patients require different dosages than younger adult patients. Taking into account age-related changes, such as decreased renal function and changes in hematological parameters, special caution is recommended when administering the drug in this age group.
Recommended related hot articles: /newsDetail/77094.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)